DAS 28 in Belgium. Prof. F. De Keyser. Introduction of DAS 28 in Belgian rheumatology. Background RTX reimbursement since June 2007 K55 nomenclature since Feb. 2009 1) Why the DAS 28 ? 2) Which cut-off should alert for a change in therapy? 3) Rituximab and DAS 28. 1) Why DAS 28 ?.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Prof. F. De Keyser
1) Why the DAS 28 ?
2) Which cut-off should alert for a change in therapy?
3) Rituximab and DAS 28
Because DAS 28 best correlates with the expert’s satisfaction about control of disease activity
A cut-off value provides a good balance between sensitivity and specificity for change of therapy
Belgian criteria for rituximab retreatment in RA patients failed on anti-TNF
DAS 28 response (w16)
DAS 28 ≥ 3.2